Cargando…
PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells
BACKGROUND: The protein kinase C (PKC) family comprises distinct classes of proteins, many of which are implicated in diverse cellular functions. Protein tyrosine kinase C theta isoform (PRKCQ)/PKCθ, a member of the novel PKC family, may have a distinct isoform-specific role in breast cancer. PKCθ i...
Autores principales: | Byerly, Jessica, Halstead-Nussloch, Gwyneth, Ito, Koichi, Katsyv, Igor, Irie, Hanna Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034539/ https://www.ncbi.nlm.nih.gov/pubmed/27663795 http://dx.doi.org/10.1186/s13058-016-0749-6 |
Ejemplares similares
-
PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim
por: Byerly, Jessica H., et al.
Publicado: (2020) -
PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim
por: Park, Sun Hee, et al.
Publicado: (2015) -
PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
por: Ito, Koichi, et al.
Publicado: (2017) -
PRKCQ rs4750316 is associated with Vogt-Koyanagi-Harada syndrome in a Han Chinese population
por: Xu, Lei, et al.
Publicado: (2019) -
Genetic Variation in the REL Gene Increases Risk of Behcet’s Disease in a Chinese Han Population but That of PRKCQ Does Not
por: Chen, Feilan, et al.
Publicado: (2016)